Cardinal Capital Management Inc (North Carolina)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.83M Buy
56,890
+815
+1% +$54.3K 0.46% 68
2026
Q1
$3.52M Buy
56,075
+12
+0% +$836 0.45% 73
2025
Q4
$3.72M Buy
56,063
+7,216
+15% +$467K 0.49% 66
2025
Q3
$3.29M Buy
48,847
+1,575
+3% +$125K 0.45% 71
2025
Q2
$4.13M Buy
47,272
+1,703
+4% +$133K 0.61% 55
2025
Q1
$3.11M Buy
45,569
+1,086
+2% +$88.6K 0.48% 71
2024
Q4
$3.46M Buy
+44,483
New +$3.29M 0.54% 63

Other funds holding DXCM

Cardinal Capital Management Inc (North Carolina)'s DXCM Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) increased its DexCom (DXCM) stake by 1.5% in Q2 2026, buying an estimated $54.3K and bringing the position to 56,890 shares worth $3.83M. The position accounts for 0.46% of the portfolio, ranked #68.

Cardinal Capital Management Inc (North Carolina) first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.13M in Q2 2025. 400 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 56,890 shares of DexCom worth $3.83M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) bought 815 DexCom shares in Q2 2026, an estimated $54.3K.
  • DexCom made up 0.46% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #68 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • Cardinal Capital Management Inc (North Carolina)'s DexCom position peaked at $4.13M in Q2 2025.
  • 400 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.